Recently, a novel isoform of ALK (ALKATI) (a truncated isoform, driven from an alternative transcription initiation (ATI) site in intron 19, encoding only the intracellular domain of ALK) has been described as being expressed in ~11% of melanomas and sporadically in other human cancers [120,121]. Here, ALK is linked to melanoma.